PF-06835375

· Pfizer

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PF-06835375, covering 2023-10-30 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia [Phase 2]